非小细胞肺癌治疗的研究

新辅助Pembrolizumab治疗早期非小细胞肺癌

Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer 新辅助Pembrolizumab治疗早期非小细胞肺癌 Introduction 介绍 Neoadjuvant immune checkpoint inhibito...[详细]

Pembrolizumab联合铂基化疗治疗复发性EGFR/

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Pembrolizumab联合铂基化疗治疗复...[详细]

焦点新闻样式1

对早期NSCLC关于SBRT后特异性病因生存率局部

1.Impact of Local Control on Cause-Specific Survival After SBRT for Early-Stage NSCLC: Dynamic Prediction With Landmarking 对早期NSCLC关于SBRT后特异性病因生存率局部控制...[详细]

T3N0M0型非小细胞肺癌切除术后的生存和预后

1.Survival and Prognostic Factors of Resected T3N0M0 NSCLC T3N0M0型非小细胞肺癌切除术后的生存和预后因素 Introduction 介绍 The 8thEdition T3N0M0 category represents a heter...[详细]